|View printer-friendly version|
|September 25, 2003 4:45 p.m.|
|Teva Calls 1.5% Convertible Debentures Due 2005 For Redemption|
Jerusalem, Israel, September 25, 2003 - Teva Pharmaceutical Industries Limited (Nasdaq: TEVA) announced today that its affiliate Teva Pharmaceutical Finance, LLC (Teva Finance) has called for redemption, on October 15, 2003 all of its outstanding 1.5% convertible senior debentures due 2005 (CUSIP Nos. 88163V AA 7, U88163 AA 5 and 88163V AB 5). The aggregate principal amount currently outstanding of the debentures is approximately $550 million.